As cell cycle and surface marker stainings cannot be combined with SA-β-Gal staining for FACS analysis, we first confirmed CD44, known to be up-regulated in TIS NB cells, as an adequate surrogate FACS marker to identify senescent NB-cells ([31], Figure 3f and Suppl. The gene discussed is CD44; the disease is neuroblastoma.